News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Investors Wait With Bated Breath for ImmunoGen (IMGN)'s Ovarian Cancer Drug ASCO News     5/28/2015
Gilead (GILD), GlobeImmune (GBIM)'s Hep B Drug Flunks Phase II Study     5/27/2015
Johnson & Johnson (JNJ) Announced 10 New Approval Applications with $1 Billion Revenue Potential Each     5/27/2015
Otonomy (OTIC) Plunges After Near-Miss Stage IIb Trial for Ear Drug     5/26/2015
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial     5/21/2015
Investors Rejoice as bluebird bio (BLUE) Plots Road to First-Ever U.S. Gene Therapy Approval     5/20/2015
Amgen (AMGN)'s Migraine Drug Meets Goals in Phase II Study     5/19/2015
AbbVie (ABBV), Genentech (RHHBY) Leukemia Drug Wins Breakthrough Status Tag     5/11/2015
FDA Lifts Clinical Hold on NeuroDerm (NDRM)'s Lead Parkinson's Candidates     5/11/2015
Tiny Corbus Looks to Give Vertex (VRTX) Some Competition With Experimental Cystic Fibrosis Drug     5/6/2015
Advancing Biogen (BIIB)’s Alzheimer’s Treatment Could Cost $2.5 Billion Before Knowing if the Drug Works     4/28/2015
Celladon (CLDN) Will Lay Off Workers, Loses 80% of Value As Heart Failure Drug Flunks Phase IIb Trial     4/28/2015
Merck & Co. (MRK) Poised To Enter Oral HCV Market Dominated by Gilead (GILD) and AbbVie (ABBV)     4/27/2015
Amgen (AMGN) Boasts 51% Rise in Profit, Abandons Phase II Brodalumb Study, but Pushes Biosimilars     4/24/2015
FDA, Genervon and ALS Blogger Battle Over Clinical Trial Interpretation     4/22/2015

Featured Stories
Why Investors Shouldn't Freak Out Over Vertex (VRTX)'s Latest Trial Results     3/24/2015
Newcomers Like Aerie Pharmaceuticals, Inc. (AERI), Inotek Pharmaceuticals Corporation Aim to Shake Up Big Pharma With New Wave of Glaucoma Drugs     2/10/2015
OncoGenex Pharmaceuticals Inc. (OGXI) Retrenches, And Searches For Answers, After Failed Trial     5/22/2014
Rumor: Will Pfizer Inc. (PFE) Unveil A Breast Cancer Blockbuster At American Association for Cancer Research?     4/4/2014
Popular Weight-Lifting Supplement May Slow Huntington Disease, Massachusetts General Hospital Study     2/11/2014
Dawn of A New Sleep Drug at Merck & Co., Inc. (MRK)?     7/19/2011
Cancer Trial Patients Take Rosy View of Likely Benefit, Oregon Health & Science University (OHSU) Study     1/28/2011
Experimental Drug Panobinostat Shows Little Activity In MDS Patients, Sarah Cannon Research Institute Study     12/30/2010
Cytokinetics, Inc. (CYTK) Drug Helps ALS Patients in Small Trial     12/13/2010
American Society of Hematology: Novel Hodgkin Drug 'Dramatic' in Refractory Patients, City of Hope Study     12/7/2010
American College of Rheumatology: Anti-IL17 Drug Misses Endpoint in RA Trial, Stanford University Study     11/11/2010
American Association for Study of Liver Diseases: Early Study Shows HCV Vaccine Works, Scripps Clinic Study     11/3/2010
American Association for Study of Liver Diseases: Rapid Response for Once-Daily Protease Inhibitor, University of North Carolina Study     11/3/2010
American Academy of Ophthalmology: Glaucoma Drug Passes Early Clinical Test     10/21/2010
Ceregene, Inc. Initiates a New Controlled Phase 2b Trial of Cere-120 for Parkinson's Disease     10/19/2010
Symphogen A/S’s Antibody Mixtures Highlighted In Three Peer-Reviewed Journals     5/28/2015
Karyopharm (KPTI) Initiates STORM Clinical Trial Of Oral Selinexor (KPT-330) In Multiple Myeloma     5/28/2015
Seres Therapeutics, Inc. Announces First Patient Dosed In Phase 2 Study Of SER-109 For The Prevention Of Recurrent Clostridium Difficile Infection In Adults     5/28/2015
Edge Therapeutics Completes Enrollment In Phase 1/2 NEWTON Study Of EG-1962 For Patients With Ruptured Brain Aneurysm     5/28/2015
Pharmacyclics (PCYC) Release: Ibrutinib (IMBRUVICA) In Combination With Anti-PD-L1 Antibody (MEDI4736) Study Commences For Patients With Two Relapsed/Refractory Blood Cancers     5/28/2015
GlobeImmune, Inc. (GBIM) Announces Top Line Results From GS-4774 Phase II Trial In Virally-Suppressed Chronic HBV Patients     5/27/2015
New Study: Nusirt Technology Could Aid In Treatment Of Non-Alcoholic Steatohepatitis (NASH) And Type 2 Diabetes     5/27/2015
Novartis AG (NVS) to Show Off New Data on 21 Meds and 11 Investigational Compounds at Major Conferences     5/27/2015
Synageva BioPharma (GEVA) Submits Kanuma (Sebelipase Alfa) Application For LAL Deficiency In Japan     5/27/2015
Gordagen Commences Clinical Trial Program For Evidence-Based Nutraceuticals     5/27/2015
Innocrin Initiates Phase 2 Castration-Resistant Prostate Cancer (CRPC) Study In Men Who Have Failed Enzalutmaide Or Abiraterone     5/27/2015
Cannabis Science Inc. Brings CS-TATI-1 To The FDA With Historic Collaborative Drug Development Deal With IGXBio and Its GenePro, A DNA-Based Immunotherapeutic That Recently Received FDA Approval To Enter Into Human Trials     5/27/2015
Positive Clinical Data From ChemoCentryx, Inc. (CCXI) Phase II Trial In Diabetic Nephropathy To Be Presented At The 52nd Annual ERA-EDTA Congress     5/26/2015
Stealth Biotherapeutics Announces Positive Results In Bendavia Heart Failure Study: The PREVIEW Trial     5/26/2015
Onxeo Announces Final Data From Completed Phase II Trial Of Validive For The Prevention Of Severe Oral Mucositis In Head And Neck Cancer Patients     5/26/2015

More News
No News Posted on that date

Career Tips
The Most Exciting Companies in Biotech     5/28/2015
Corbus Will Interview Twice as Many Candidates in 2015 as Its Ranks Grow     5/28/2015
HR Exec Says Alder Biopharma Will Grow 30% in 2015, As Hunt for Candidates Continues     5/15/2015
The After-Interview Trick You’re Not Using     5/14/2015
New Networking Opportunities at Talent Connect, Over 600 Bioscience Jobs Available Now     5/14/2015
THERAVECTYS Upped Hiring Almost Five-Fold in 2014, As Biotech Booms, Says HR Head     5/1/2015
4 Phrases You’ll Need at Your Next Networking Event     4/30/2015
Avoid a Job Mismatch     4/30/2015
Sucampo (SCMP) Looks to Add to "Scientific Core" As Global Reach Grows, Says HR     4/16/2015
8 Things That are Hurting Your Resume     4/16/2015
8 Ways to Increase Your Paycheck     4/16/2015
Flexion (FLXN) CEO Discusses Pipeline and Jobs     4/3/2015
What Employers Think When They See Your LinkedIn Profile     4/2/2015
Five Ways to Build Rapport With Your Interviewer     4/2/2015
Relypsa (RLYP) Hits the Big Leagues: New Hires in Almost Every Department     3/19/2015

Other News Sources
//-->